» Articles » PMID: 37380743

Insight in Cognitive Impairment Assessed with the Cognitive Assessment Interview in a Large Sample of Patients with Schizophrenia

Abstract

The Cognitive Assessment Interview (CAI) is an interview-based scale measuring cognitive impairment and its impact on functioning in subjects with schizophrenia (SCZ). The present study aimed at assessing, in a large sample of SCZ (n = 601), the agreement between patients and their informants on CAI ratings, to explore patients' insight in their cognitive deficits and its relationships with clinical and functional indices. Agreement between patient- and informant-based ratings was assessed by the Gwet's agreement coefficient. Predictors of insight in cognitive deficits were explored by stepwise multiple regression analyses. Patients reported lower severity of cognitive impairment vs. informants. A substantial to almost perfect agreement was observed between patients' and informants' ratings. Lower insight in cognitive deficits was associated to greater severity of neurocognitive impairment and positive symptoms, lower severity of depressive symptoms, and older age. Worse real-life functioning was associated to lower insight in cognitive deficit, worse neurocognitive performance, and worse functional capacity. Our findings indicate that the CAI is a valid co-primary measure with the interview to patients providing a reliable assessment of their cognitive deficits. In the absence of informants with good knowledge of the subject, the interview to the patient may represent a valid alternative.

Citing Articles

Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia.

Giuliani L, Sanmarchi F, Mucci A, Rucci P, Caporusso E, Bucci P Schizophrenia (Heidelb). 2025; 11(1):1.

PMID: 39753575 PMC: 11698981. DOI: 10.1038/s41537-024-00545-2.


Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations.

Vita A, Barlati S, Cavallaro R, Mucci A, Riva M, Rocca P Front Psychiatry. 2024; 15:1451832.

PMID: 39371908 PMC: 11450451. DOI: 10.3389/fpsyt.2024.1451832.


Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia.

Pezzella P, Caporusso E, Mucci A, Bucci P, Giordano G, Amore M Schizophr Bull Open. 2024; 5(1):sgae020.

PMID: 39221412 PMC: 11362673. DOI: 10.1093/schizbullopen/sgae020.

References
1.
Moritz S, Balzan R, Bohn F, Veckenstedt R, Kolbeck K, Bierbrodt J . Subjective versus objective cognition: Evidence for poor metacognitive monitoring in schizophrenia. Schizophr Res. 2016; 178(1-3):74-79. DOI: 10.1016/j.schres.2016.08.021. View

2.
Stein D, Shoptaw S, Vigo D, Lund C, Cuijpers P, Bantjes J . Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration. World Psychiatry. 2022; 21(3):393-414. PMC: 9453916. DOI: 10.1002/wps.20998. View

3.
Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P . Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives. Schizophr Res. 2016; 175(1-3):154-160. DOI: 10.1016/j.schres.2016.04.043. View

4.
Sass L . Subjectivity, psychosis and the science of psychiatry. World Psychiatry. 2022; 21(2):165-166. PMC: 9077602. DOI: 10.1002/wps.20986. View

5.
Addington D, Addington J, Maticka-Tyndale E . Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl. 1993; (22):39-44. View